# Greenwich LifeSciences, Inc.: filings

GLSI · Nasdaq · CIK 1799788 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/glsi.md) · [Financials](/companies/glsi/financials.md) · [Filings](/companies/glsi/filings.md) · [Insiders](/companies/glsi/insiders.md)

## Reports and events: 70 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 135, 8-K 31, 10-Q 18, 3 9, CORRESP 9, UPLOAD 7, 10-K 6, DEF 14A 6, NT 10-Q 6, DEFA14A 5, ARS 4, EFFECT 4, S-1/A 4, 424B4 3, FWP 3, NT 10-K 3, 424B3 2, DRS 2, DRSLTR 2, S-1 2, S-3 2, S-8 2, SC 13D 2, 10-K/A 1, 3/A 1, 424B5 1, 4/A 1, 8-A12B 1, CERT 1, D 1, DRS/A 1, S-1MEF 1, S-3/A 1, SC 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:30 ET | [DEF 14A](/filings/0001493152-26-048537.md) | Proxy statement, period 2026-10-26 | 0001493152-26-048537 |
| 2026-08-11 | 16:30 ET | [10-Q](/filings/0001493152-26-037147.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037147 |
| 2026-06-04 | 18:19 ET | [10-Q](/filings/0001493152-26-027150.md) | Quarterly report, period 2026-03-31 | 0001493152-26-027150 |
| 2026-06-01 | 16:56 ET | [10-K](/filings/0001493152-26-026651.md) | Annual report, period 2025-12-31 | 0001493152-26-026651 |
| 2025-12-18 | 16:30 ET | [8-K](/filings/0001493152-25-028361.md) | 5.07 Shareholder vote results | 0001493152-25-028361 |
| 2025-11-14 | 16:30 ET | [10-Q](/filings/0001493152-25-023539.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023539 |
| 2025-11-03 | 17:07 ET | [DEF 14A](/filings/0001493152-25-020623.md) | Proxy statement, period 2025-11-03 | 0001493152-25-020623 |
| 2025-08-14 | 16:30 ET | [10-Q](/filings/0001641172-25-024066.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024066 |
| 2025-07-24 | 16:30 ET | [8-K](/filings/0001641172-25-020843.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-020843 |
| 2025-05-20 | 16:30 ET | [10-Q](/filings/0001641172-25-011731.md) | Quarterly report, period 2025-03-31 | 0001641172-25-011731 |
| 2025-04-15 | 16:30 ET | [10-K](/filings/0001641172-25-004819.md) | Annual report, period 2024-12-31 | 0001641172-25-004819 |
| 2024-12-19 | 16:15 ET | [8-K](/filings/0001493152-24-050777.md) | 5.07 Shareholder vote results | 0001493152-24-050777 |
| 2024-11-14 | 16:30 ET | [10-Q](/filings/0001493152-24-045938.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045938 |
| 2024-11-01 | 16:10 ET | [DEF 14A](/filings/0001493152-24-043327.md) | Proxy statement, period 2024-11-01 | 0001493152-24-043327 |
| 2024-08-14 | 16:33 ET | [10-Q](/filings/0001493152-24-032278.md) | Quarterly report, period 2024-06-30 | 0001493152-24-032278 |
| 2024-06-17 | 06:20 ET | [8-K](/filings/0001493152-24-024035.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-024035 |
| 2024-05-20 | 16:30 ET | [10-Q](/filings/0001493152-24-020710.md) | Quarterly report, period 2024-03-31 | 0001493152-24-020710 |
| 2024-04-15 | 16:30 ET | [10-K](/filings/0001493152-24-014625.md) | Annual report, period 2023-12-31 | 0001493152-24-014625 |
| 2024-02-20 | 16:15 ET | [8-K](/filings/0001493152-24-007223.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-007223 |
| 2024-02-14 | 16:10 ET | [8-K](/filings/0001493152-24-006664.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-006664 |
| 2023-12-15 | 16:15 ET | [8-K](/filings/0001493152-23-045048.md) | 5.07 Shareholder vote results | 0001493152-23-045048 |
| 2023-10-25 | 17:38 ET | [DEF 14A](/filings/0001493152-23-038176.md) | Proxy statement, period 2023-10-24 | 0001493152-23-038176 |
| 2023-10-19 | 16:15 ET | [10-Q](/filings/0001493152-23-037702.md) | Quarterly report, period 2023-09-30 | 0001493152-23-037702 |
| 2023-08-21 | 16:05 ET | [10-Q](/filings/0001493152-23-029605.md) | Quarterly report, period 2023-06-30 | 0001493152-23-029605 |
| 2023-05-22 | 16:10 ET | [10-Q](/filings/0001493152-23-018539.md) | Quarterly report, period 2023-03-31 | 0001493152-23-018539 |
| 2023-04-13 | 06:05 ET | [8-K](/filings/0001493152-23-012053.md) | 8.01 Other events | 0001493152-23-012053 |
| 2023-03-31 | 16:16 ET | [10-K](/filings/0001493152-23-010284.md) | Annual report, period 2022-12-31 | 0001493152-23-010284 |
| 2023-03-13 | 06:05 ET | [8-K](/filings/0001493152-23-007316.md) | 8.01 Other events | 0001493152-23-007316 |
| 2022-12-09 | 16:15 ET | [8-K](/filings/0001493152-22-035047.md) | 5.07 Shareholder vote results | 0001493152-22-035047 |
| 2022-11-14 | 16:18 ET | [10-Q](/filings/0001493152-22-032057.md) | Quarterly report, period 2022-09-30 | 0001493152-22-032057 |
| 2022-10-19 | 17:12 ET | [DEF 14A](/filings/0001493152-22-028917.md) | Proxy statement, period 2022-10-19 | 0001493152-22-028917 |
| 2022-08-15 | 17:06 ET | [10-Q](/filings/0001493152-22-022956.md) | Quarterly report, period 2022-06-30 | 0001493152-22-022956 |
| 2022-07-12 | 09:16 ET | [8-K](/filings/0001493152-22-019051.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-019051 |
| 2022-07-12 | 06:10 ET | [8-K](/filings/0001493152-22-019038.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-019038 |
| 2022-07-11 | 17:01 ET | [8-K](/filings/0001493152-22-019022.md) | 8.01 Other events | 0001493152-22-019022 |
| 2022-06-24 | 17:17 ET | [10-K/A](/filings/0001493152-22-017739.md) | Annual report, amended, period 2021-12-31 | 0001493152-22-017739 |
| 2022-05-20 | 17:00 ET | [10-Q](/filings/0001493152-22-014639.md) | Quarterly report, period 2022-03-31 | 0001493152-22-014639 |
| 2022-03-21 | 17:24 ET | [10-K](/filings/0001493152-22-007377.md) | Annual report, period 2021-12-31 | 0001493152-22-007377 |
| 2021-12-15 | 16:15 ET | [8-K](/filings/0001493152-21-031573.md) | 5.07 Shareholder vote results | 0001493152-21-031573 |
| 2021-12-13 | 06:04 ET | [8-K](/filings/0001493152-21-031170.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-031170 |
| 2021-11-15 | 16:38 ET | [10-Q](/filings/0001493152-21-028660.md) | Quarterly report, period 2021-09-30 | 0001493152-21-028660 |
| 2021-11-10 | 06:52 ET | [8-K](/filings/0001493152-21-027743.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-027743 |
| 2021-10-19 | 08:06 ET | [DEF 14A](/filings/0001493152-21-025748.md) | Proxy statement, period 2021-10-19 | 0001493152-21-025748 |
| 2021-08-13 | 16:16 ET | [10-Q](/filings/0001493152-21-019718.md) | Quarterly report, period 2021-06-30 | 0001493152-21-019718 |
| 2021-06-10 | 07:00 ET | [8-K](/filings/0001493152-21-013960.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-013960 |
| 2021-06-09 | 07:00 ET | [8-K](/filings/0001493152-21-013862.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-013862 |
| 2021-05-20 | 16:33 ET | [10-Q](/filings/0001493152-21-012362.md) | Quarterly report, period 2021-03-31 | 0001493152-21-012362 |
| 2021-04-20 | 07:00 ET | [8-K](/filings/0001493152-21-009204.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-009204 |
| 2021-04-15 | 07:00 ET | [8-K](/filings/0001493152-21-008809.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-008809 |
| 2021-04-13 | 07:00 ET | [8-K](/filings/0001493152-21-008601.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-008601 |

Page 1 of 2. [Older](/companies/glsi/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:53 ET. No prices; not investment advice.